Title : Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib.

Pub. Date : 2011 Nov

PMID : 22005476






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib. Erlotinib Hydrochloride ALK receptor tyrosine kinase Homo sapiens